Literature DB >> 1681581

Nephropathia epidemica (hemorrhagic fever with renal syndrome) in Scandinavia.

B Settergren1.   

Abstract

Nephropathia epidemica (NE) in Scandinavia is a zoonosis caused by Puumala virus. The main animal reservoir is the bank vole. NE predominantly affects men. Its annual incidence varies in a cyclic fashion, with peaks occurring every third to fourth year. The clinical picture of NE in Scandinavia is similar to that of hemorrhagic fever with renal syndrome in other parts of the world, although NE generally has a milder course. The case-fatality rate is approximately 0.2%. The most common clinical findings in NE are an acute onset of symptoms, fever (greater than or equal to 38 degrees C), oliguria, headache, back pain, and polyuria. Hemorrhagic manifestations are seen in about one-third of cases, and up to 5% of patients have gastrointestinal bleeding or disseminated intravascular coagulation. Thrombocytopenia occurs in a majority of patients. In the acute phase, the glomerular filtration rate is markedly decreased and tubular dysfunction is evident. Most patients with NE recover within 6 months.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681581     DOI: 10.1093/clinids/13.4.736

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  16 in total

1.  Clinical quiz. Nephropathia epidemica. Specific IgM antibodies against Puumalavirus can be found in serum.

Authors:  E Esbjörner; C Ahlm
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

2.  Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infection.

Authors:  Outi Laine; Lotta Joutsi-Korhonen; Satu Mäkelä; Jussi Mikkelsson; Tanja Pessi; Sari Tuomisto; Heini Huhtala; Daniel Libraty; Antti Vaheri; Pekka Karhunen; Jukka Mustonen
Journal:  Thromb Res       Date:  2011-11-30       Impact factor: 3.944

3.  Hantavirus pulmonary syndrome: Report of four Alberta cases.

Authors:  A E Singh; D H Werker; L R Boychuk; L J Miedzinski
Journal:  Can J Infect Dis       Date:  1995-07

Review 4.  New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention--a review.

Authors:  Martin Zeier; Michaela Handermann; Udo Bahr; Baldur Rensch; Sandra Müller; Roland Kehm; Walter Muranyi; Gholamreza Darai
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

5.  The clinical spectrum of human hantavirus infection in Somerset, UK.

Authors:  J V Pether; G Lloyd
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

6.  A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses.

Authors:  B Hjelle; S Jenison; N Torrez-Martinez; T Yamada; K Nolte; R Zumwalt; K MacInnes; G Myers
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Emergence of hantaviral disease in the southwestern United States.

Authors:  B Hjelle; S Jenison; G Mertz; F Koster; K Foucar
Journal:  West J Med       Date:  1994-11

8.  Belgrade and Hantaan hantaviruses--the causative agents of severe haemorrhagic fever with renal syndrome in children in Serbia.

Authors:  R Bogdanović; A Gligić; V Nikolić; M Ognjanović; M Marković; L Sarjanović
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

9.  Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden.

Authors:  C Ahlm; M Linderholm; P Juto; B Stegmayr; B Settergren
Journal:  Epidemiol Infect       Date:  1994-08       Impact factor: 2.451

10.  Upregulation of IFN-γ and IL-12 is associated with a milder form of hantavirus hemorrhagic fever with renal syndrome.

Authors:  S F Khaiboullina; E V Martynova; Z L Khamidullina; E V Lapteva; I V Nikolaeva; V V Anokhin; V C Lombardi; A A Rizvanov
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-19       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.